百花医药 (600721.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(百花医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 98,499,939.2691,503,497.9075,710,434.2293,526,646.9692,595,170.97104,966,261.6658,796,482.88
 营业收入(元) 98,499,939.2691,503,497.9075,710,434.2293,526,646.9692,595,170.97104,966,261.6658,796,482.88
二、营业总成本(元) 77,849,161.1877,214,796.0965,115,036.7795,352,820.6085,327,531.8188,622,265.5254,191,831.84
 营业成本(元) 48,599,430.4250,349,858.9738,651,094.9060,320,434.5254,195,623.4564,024,697.6331,678,242.80
 研发费用(元) 8,608,060.966,455,651.716,139,950.6310,200,029.886,801,599.736,126,649.264,354,071.54
 营业税金及附加(元) 1,221,685.381,294,845.37927,582.471,439,648.61842,150.691,321,027.501,191,462.46
 销售费用(元) 2,861,546.962,881,260.012,617,881.436,353,496.873,753,612.142,683,162.672,638,185.44
 管理费用(元) 16,716,609.1616,575,296.8716,861,033.6017,230,668.6519,792,595.0814,499,767.7214,323,160.17
 财务费用(元) -158,171.70-342,116.84-82,506.26-191,457.93-58,049.28-33,039.266,709.43
  其中:利息费用(元) -----49,386.2663,193.47
  其中:利息收入(元) 244,965.40387,364.27126,403.03242,536.74103,610.5598,706.8876,904.65
 资产减值损失(元) -15,897,104.77-5,845,888.09-3,710,225.94-44,798,712.23-6,003,937.62-4,834,687.36-1,769,053.71
 信用减值损失(元) -721,365.83-1,581,390.90-271,062.14-1,119,775.52-151,537.94-258,021.99-527,916.55
三、其他经营收益
 加:投资收益(元) 1,421,311.23461,882.24485,715.061,517,068.69-182,655.00-1,415,682.55-684,735.13
  其中:对联营企业和合营企业的投资收益(元) 1,008,228.66126,631.48293,693.041,246,668.82-385,649.56-1,586,109.63-767,425.25
 资产处置收益(元) --4,831.32----
 其他收益(元) 265,038.56305,601.65320,736.12748,408.48807,340.48376,891.52388,403.94
四、营业利润(元) 5,718,657.277,628,906.717,425,391.87-44,701,076.681,736,849.0810,212,495.762,011,349.59
 加:营业外收入(元) 20,876.3813,200.6329,973.97-150,247.6718,805.46236,888.481,097.20
 减:营业外支出(元) 73,013.47357,418.8259,905.35273,335.54402,318.26798,819.817,178.42
五、利润总额(元) 5,666,520.187,284,688.527,395,460.49-45,124,659.891,353,336.289,650,564.432,005,268.37
 减:所得税费用(元) 974,289.89971,985.29708,607.29598,559.97671,191.47715,885.45626,377.79
六、净利润(元) 4,692,230.296,312,703.236,686,853.20-45,723,219.86682,144.818,934,678.981,378,890.58
(一)按经营持续性分类
  持续经营净利润(元) 4,692,230.296,312,703.236,686,853.20-45,723,219.86682,144.818,934,678.981,378,890.58
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 4,692,230.296,312,703.236,686,853.20-45,750,684.85701,253.118,922,304.621,372,156.64
  少数股东损益(元) -----12,374.366,733.94
 扣除非经常性损益后的净利润(元) 4,098,404.486,051,401.966,225,735.69-47,083,699.43103,495.148,970,259.72945,756.27
七、每股收益
 一、基本每股收益(元) 0.010.020.02-0.12-0.02-
 二、稀释每股收益(元) 0.010.020.02-0.12-0.02-
九、综合收益总额(元) 4,692,230.296,312,703.236,686,853.20-45,952,013.21682,144.818,934,678.981,378,890.58
 归属于母公司所有者的综合收益总额(元) 4,692,230.296,312,703.236,686,853.20-45,979,478.20701,253.11--
公告日期 2023-10-272023-08-312023-04-262023-04-122022-10-272022-08-242022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院